Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Rain 57° Rain
News >  Nation/World

FDA approves double-chin fat drug

Stuart Pfeifer Los Angeles Times

LOS ANGELES – The Food and Drug Administration has approved a Westlake Village, California, company’s injectable drug as a treatment to reduce double-chin fat in adults.

Kythera Biopharmaceuticals Inc. said in a news release that injections of the drug have been shown in clinical studies to be safe and effective in reducing fat under the chin.

It will sell the drug under the brand name Kybella. The company plans to launch the drug this summer through physicians who complete a training program.

“For the first time, people have access to an FDA-approved, nonsurgical treatment” for double chins, said Keith Leonard, chief executive of Kythera.

In an interview with the Los Angeles Times in 2013, Leonard said he thought the drug could eventually generate more than $500 million in annual sales.

“We really think we’re going to be the next big thing in aesthetics,” he said.

Kybella will be administered during in-office doctor visits that typically last 15 to 20 minutes. Many patients saw visible results after two to four visits, the company said, but up to six treatments may be administered.

In addition to physical benefits, patients in the clinical trials reported being less self-conscious, Kythera said.

Fat under the chin can affect men and women, regardless of age or weight.

“I see many patients who have undesirable fullness under the chin, even though they may have an otherwise balanced and harmonious facial appearance and be in great physical shape,” said Dr. Derek Jones, a University of California, Los Angeles dermatology professor and lead investigator in clinical studies of the drug.

Fat below the chin “is often resistant to diet and exercise” and could be caused by aging or genetics, Jones said.

Dr. Michael Edwards, president of the American Society for Aesthetic Plastic Surgery, said he believes Kybella is a “true innovation in the aesthetic industry.”

“We are excited about its potential,” he said.

The Spokesman-Review Newspaper

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Active Person

Subscribe now to get breaking news alerts in your email inbox

Get breaking news delivered to your inbox as it happens.